MedGenome: Funding, Investors & Team (Sep 2026)
MedGenome is a developer of sequencing genomics-based diagnostics and research platform intended to improve global health. The company's platform applies genomics technologies, bioinformatics, computing, and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.
MedGenome has raised $105M across 2 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Aug 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MedGenome Company Profile and Key Stats
Latest funding round on record: Aug 2022.
MedGenome Funding Rounds
MedGenome raised $55.0M in an undisclosed round announced in Apr 2020.
2.3 years later, an undisclosed round of $50.0M was announced in Aug 2022.
MedGenome Founders and Leadership Team
Contact details for the MedGenome team: 2 of 2 have an email address on file.
Start 14-day free trial →MedGenome Funding Compared to Other Biotechnology Startups
MedGenome's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MedGenome in Biotechnology and Bangalore
Companies Similar to MedGenome
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
BrainSightAI is a software platform that uses MRI technology to improve accuracy in neurological and…
MedGenome Funding FAQs
What does MedGenome do?
MedGenome is a developer of sequencing genomics-based diagnostics and research platform intended to improve global health. The company's platform applies genomics technologies, bioinformatics, computing, and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.
How much funding has MedGenome raised?
MedGenome has raised $105M across 2 rounds on record. The most recent is an undisclosed round of $50.0M announced in Aug 2022.
When did MedGenome last raise funding?
MedGenome's most recent funding round on record is an undisclosed round of $50.0M, announced in Aug 2022.
Who is the CEO of MedGenome?
Sam Santhosh is listed as CEO at MedGenome.
Where is MedGenome headquartered?
MedGenome is based in Bangalore, Karnataka, India.
How many employees does MedGenome have?
MedGenome is in the 501-1000 employee band.
How does MedGenome's funding compare to other Biotechnology startups?
MedGenome's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's MedGenome Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MedGenome is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.